Vaccine-makers$CureVac (CVAC.US)$and$Novavax (NVAX.US)$rose sharply Monday, apparently gaining ground on a U.S. Centers for Disease Control report showing increased cases of COVID-19, RSV and other diseases.
CVAX soared as much as 21.8% to a $4.41 session peak, while NVAX rose to as high as $10.03, up 13.3% on the day.
The stocks popped after the CDC said in its weekly national summary Friday that U.S. cases of COVID, influenza and RSV are all going up. Vaccines can prevent all three diseases or reduce their severity.
"COVID-19 activity is increasing in most areas of the country, with high COVID-19 wastewater levels and increasing emergency department visits and laboratory percent positivity," the public-health agency wrote in its report. "Based on CDC modeled estimates of epidemic growth, we predict COVID-19 illness will continue to increase in the coming weeks as it usually does in the winter."
The CDC also said "activity is very high in many areas of the country, particularly in young children. Emergency department visits and hospitalizations are highest in children and hospitalizations are elevated among older adults in some areas."
Lastly, the agency noted that seasonal influenza "continues to increase and is elevated across most of the country."
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
BelleWeather
:
Also, first US bird flu related death reported (and some frightening emerging diseases abroad…) Ack. But the Novovax calls that I held so long that there was no point in selling magically recovered, so, brightside.
RDK79 : shocked clorox didnt sky-rocket too, maybe after the inauguration:))
stderr RDK79 : Buy toilet paper
RDK79 stderr : have dozens of pallets in the bunker
BelleWeather : Also, first US bird flu related death reported (and some frightening emerging diseases abroad…) Ack. But the Novovax calls that I held so long that there was no point in selling magically recovered, so, brightside.
104157900 : is it possible go back ATH?